| ||
| Clovis teams with Roche on companion diagnostic for covalent cancer drug FierceBiotech The goal of this new pact is to develop a diagnostic test for EGFR mutations found in non-small cell lung cancer, including the EGFR T790M mutation. Roche officials touted the pact as a clear indication of its market-leading rep in the field of ... See all stories on this topic » |
This once a day Google Alert is brought to you by Google.
Remove this alert.
Create another alert.
Manage your alerts.
No comments:
Post a Comment